FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1459454017 Cutaneous AND/OR transdermal dosage form (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
    161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    forme pharmaceutique pour usage transdermique et/ou cutané Is a Type of drug preparation false Inferred relationship Existential restriction modifier (core metadata concept)
    forme pharmaceutique pour usage transdermique et/ou cutané Is a Dose form by site prepared for (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Unguentum Cocois Co Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrous wool fat+zinc oxide 4/8% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Soap substitute+zinc oxide 5% cream wash Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Dimethicone+calamine+zinc oxide 20/1.5/7.5% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Urea 100 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Lauromacrogol 30 mg/g and urea 50 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Urea+lactic acid 10/5% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Cetyl dimethicone 5% bath oil (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Soya oil+mixed lauromacrogols 82.95/15% bath oil Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Soya oil 84.75% bath oil (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Talc dusting powder BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Zinc+starch+talc dusting powder BPC (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Calamine compound application BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Calamine 4% aqueous cream BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Calamine lotion BP (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Calamine oily lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Calamine 15% ointment BP Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Crotamiton 10% lotion (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Crotamiton 100 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Lidocaine 20 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Lignocaine+prilocaine 2.5%/2.5% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Benzocaine 30 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Benzocaine+triclosan 1/0.2% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Diphenhydramine hydrochloride 2% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely doxepin hydrochloride 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone creams (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 1 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone ointments Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate 10 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Alclometasone dipropionate 0.05% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Alclometasone dipropionate 500 microgram/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 250 microgram/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone valerate 0.12% foam (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.1% scalp application (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.1% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.1% ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.1% lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+salicylic acid 0.05/3% scalp application Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.05% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clobetasone butyrate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasone butyrate 500 microgram/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Desoxymethasone 0.05% oily cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 1 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 0.1% oily cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 1 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 0.3% oily cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 0.3% ointment (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 62.5 microgram/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 0.00625% cream (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 25 microgram/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 250 microgram/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocortolone 0.5% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocortolone 0.5% ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fludroxycortide 125 microgram/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely halcinonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone butyrate 1 mg/g cutaneous emulsion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone butyrate 1 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone butyrate 0.1% lipocream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone butyrate 0.1% scalp lotion (substance) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone furoate 1 mg/g cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone furoate 1 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Existential restriction modifier (core metadata concept)

    Start Previous Page 3 of 13 Next End

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start